Neuraxis, Inc (NRXS): R&D Expense
$493.6K
Year ended 2025-12-31
$791.3K
Trailing 12 months to 2026-09-30
+29.8%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $493.6K | +13.8% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $433.6K | +156.1% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $169.3K | -25.0% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $225.6K | n/a | 2024-04-16, From 2022-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Neuraxis, Inc (NRXS) | 2025-12-31 | $493.6K | +13.8% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $545.0K | +5.4% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $501.5K | -33.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $469.0K | -10.8% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $3.94M | +20.5% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $459.1K | +392.0% |
Compare NRXS, ADMT, NUWE, ESMC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗